Related Experiment Video
Updated: Jun 30, 2025
09:18
Electrophysiological Measurements and Analysis of Nociception in Human Infants
Published on: December 20, 2011
17.2K
Compensation in Neonatal Clinical Trials: A Perspective.
Apoorva Mathur1, Dilip Raja1, Anju Sinha2
1Division of Reproductive, Child Health and Nutrition, Indian Council of Medical Research (ICMR), New Delhi, India.
Indian Pediatrics
|March 22, 2024
Summary
Current Indian guidelines for clinical trial compensation inadequately protect neonates. This article proposes a birthweight-based compensation formula to address this critical gap for neonatal clinical trials.
Area of Science:
- Neonatal research
- Clinical trial regulation
- Medical ethics
Background:
- Clinical trials are crucial for evidence-based medicine.
- India has guidelines for trial participant compensation.
- Current guidelines lack specificity for pediatric and neonatal trials.
Purpose of the Study:
- To examine challenges in neonatal clinical trial compensation.
- To highlight the inadequacy of existing Indian guidelines for neonates.
- To propose an improved compensation framework.
Main Methods:
- Analysis of existing compensation guidelines.
- Examination of challenges faced in neonatal clinical trial insurance procurement (ProSPoNS trial example).
- Development of a template for a differential compensation formula.
Main Results:
- Existing compensation formulas present challenges for neonatal trials.
- Neonates are a particularly vulnerable population in clinical trials.
- A birthweight-based differential formula is proposed.
Conclusions:
- There is a significant need to revise Indian compensation guidelines for neonatal clinical trials.
- Incorporating factors like birthweight can improve compensation equity.
- Revised guidelines are essential for protecting vulnerable infant participants.
